Drug Profile
Research programme: cysteinyl leukotriene receptor 1/2 inhibitors - Ono Pharmaceutical
Alternative Names: ONO-RS-531Latest Information Update: 25 May 2010
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 25 Oct 2005 Preclinical trials in Asthma in Japan (unspecified route)